FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
Completed
Anthera Pharmaceuticals
Phase 2
The objective of this study is to evaluate the safety and efficacy of A 002 when added to
high dose atorvastatin in subjects with an acute coronary syndrome (ACS)
VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
Terminated
Anthera Pharmaceuticals
Phase 3
The objective of this study is to evaluate the safety and efficacy of short-term A-002
treatment on morbidity and mortality when added to atorvastatin and standard of care in
subjects with an acute coronary syndrome (ACS).
A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function
Terminated
Anthera Pharmaceuticals
Phase 1
The purpose of this study is to compare and evaluate the pharmacokinetic characteristics and
the safety of varespladib methyl in mild or moderate renal impairment patients and healthy
volunteers.
Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite
Recruiting
Premier Research International LLC
Phase 2
This is a multicenter, randomized, double-blind, placebo-controlled, phase 2 study designed
to evaluate the safety, tolerability and efficacy of varespladib-methyl, concurrently with
standard of care (SOC), in subjects bitten by venomous snakes.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
